A simplified and modified procedure to culture brain glioma stem cells from clinical specimens

Oncology Letters

Volumn 3, Issue 1, 2012, Pages 50-54

  Qiu, Bo ^a   Zhang, Dongyong ^a   Tao, Jun ^a   Wu, Anhua ^a   Wang, Yunjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Brain glioma stem cells; Cd133; Glioma; Proliferation; Self renewal

Indexed keywords

BETA TUBULIN; CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER STEM CELL; CANCER SURGERY; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CULTURE MEDIUM; FEMALE; GLIOMA; GLIOMA CELL; GLIOMA STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PLURIPOTENT STEM CELL; PROGENY; TARGET CELL; TUMOR CELL CULTURE; TUMOR GROWTH;

EID: 84855252105     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.433     Document Type: Article

References (22)

1. Hess KR, Broglio KR and Bondy ML: Adult glioma incidence trends in the United States, 1977-2000. Cancer 101: 2293-2299, 2004.
2. Reardon DA, Rich JN, Friedman HS and Bigner DD: Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253-1265, 2006.
3. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006.
4. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
5. Hemmati HD, Nakano I, Lazareff JA, et al: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003.
6. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
7. Tunici P, Irvin D, Liu G, et al: Brain tumor stem cells: new targets for clinical treatments? Neurosurg Focus 20: 27, 2006.
8. Yi L, Zhou ZH, Ping YF, et al: Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod Pathol 20: 1061-1068, 2007.
9. Beier D, Hau P, Proescholdt M, et al: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015, 2007.
10. Huang Q, Dong J, Zhu YD, et al: [Isolation and culture of tumor stem cells from human brain glioma tissues]. Zhonghua Zhong Liu Za Zhi 28: 331-333, 2006.
11. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
12. Claus EB and Black PM: Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 106: 1358-1363, 2006.
13. Davis FG, Freels S, Grutsch J, Barlas S and Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88: 1-10, 1998.
14. Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
15. Taylor MD, Poppleton H, Fuller C, et al: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8: 323-335, 2005.
16. Yuan X, Curtin J, Xiong Y, et al: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400, 2004.
17. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786, 2004.
18. Lee J, Kotliarova S, Kotliarov Y, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403, 2006.
19. Wang J, Sakariassen PO, Tsinkalovsky O, et al: CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768, 2008.
20. Chua C, Zaiden N, Chong KH, et al: Characterization of a side population of astrocytoma cells in response to temozolomide. J Neurosurg 109: 856-866, 2008.
21. Kelly PN, Dakic A, Adams JM, Nutt SL and Strasser A: Tumor growth need not be driven by rare cancer stem cells. Science 317: 337, 2007.
22. Kennedy JA, Barabe F, Poeppl AG, Wang JC and Dick JE: Comment on 'Tumor growth need not be driven by rare cancer stem cells'. Science 318: 1722, 2007.